A Prospective Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer
The investigators will also be assessing the following:
1. Whether polymer-based markers can be adequately visualized on daily stereoscopic
imaging compared to gold seed markers.
2. Whether polymer-based markers are visible on ultrasound imaging.
3. To determine if the polymer-based marker produces fewer artifacts on treatment planning
CT scans than gold markers.
Observational Model: Case-Only, Time Perspective: Retrospective
Ultrasound versus MRI image fusion for daily prostate positioning
Determine if prostate target delineation obtained through an ultrasound based system is equivalent in accuracy to the MRI image fusion method, and if alighment crrection vectors obtained from ultransound imaging are of equivalent accuracy to orthogonal X-ray imaging for daily prostate positioning.
John Chang, MD
ProCure Proton Therapy Center
United States: Institutional Review Board
|ProCure Proton Therapy Center||Warrenville, Illinois 60555|